InsiderTrades.com logo

DRMA Insider Trading

Insider Ownership Percentage: 21.90%
Insider Buying (Last 12 Months): $1,270.00
Insider Selling (Last 12 Months): $0.00

Dermata Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Dermata Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Dermata Therapeutics Share Price & Price History

Current Price: $0.84
Price Change: ▼ Price Decrease of -0.0336 (-3.84%)
As of 10/29/2026 04:00 PM ET

This chart shows the closing price history over time for DRMA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Dermata Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/17/2026Maria E. Bedoya Toro MuneraSVPBuy1,000$1.27$1,270.001,012View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Dermata Therapeutics (NASDAQ:DRMA)

8.67% of Dermata Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DRMA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Dermata Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/16/2026Clear Street Group Inc.17,000$39K0.0%N/A0.599%Search for SEC Filing on Google Icon
11/17/2025Armistice Capital LLC81,654$0.41M0.0%-74.7%11.973%Search for SEC Filing on Google Icon
8/14/2025Armistice Capital LLC322,179$0.19M0.0%-21.6%50.498%Search for SEC Filing on Google Icon
5/15/2025Armistice Capital LLC411,000$0.44M0.0%+1,411.0%6.813%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC28,000$67K0.0%N/A4.982%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC218,000$0.13M0.0%N/A6.158%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC75,538$79K0.0%+34.2%2.368%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC56,285$92K0.0%N/A2.405%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC32,105$53K0.0%N/A1.372%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC70,808$37K0.0%N/A0.701%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Dermata Therapeutics logo
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Read More on Dermata Therapeutics

Today's Range

Now: $0.84
Low: $0.82
High: $0.88

50 Day Range

MA: $1.13
Low: $0.66
High: $1.72

52 Week Range

Now: $0.84
Low: $0.60
High: $4.66

Volume

31,689 shs

Average Volume

1,699,752 shs

Market Capitalization

$4.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66

Who are the company insiders with the largest holdings of Dermata Therapeutics?

Dermata Therapeutics' top insider shareholders include:
  1. Munera Maria E Bedoya-Toro (SVP)
Learn More about top insider investors at Dermata Therapeutics.

Dermata Therapeutics Active Insiders

Munera Maria E Bedoya-Toro
Senior Vice President of Regulatory Affairs and Quality Assurance